El En SpA
OTC:ELEAF
El En SpA
OTC:ELEAF
Price:
16.6
USD
Market Closed
Market Cap:
$1.3B
Relative Value
The Relative Value of one
ELEAF
stock under the Base Case scenario is
10.39
USD.
Compared to the current market price of 16.6 USD,
El En SpA
is
Overvalued by 37%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ELEAF
Relative Value
Base Case
10.39
USD
Overvaluation 37%
Multiples Across Competitors
ELEAF Competitors Multiples
El En SpA Competitors
El En SpA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IT |
|
El En SpA
OTC:ELEAF
|
1.1B USD | 1.8 | 19.9 | 9.9 | 11.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.8B USD | 4.3 | 29.3 | 16.8 | 23 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.9B USD | 17.3 | 61 | 46.3 | 56.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.8B USD | 5.6 | 43 | 21.8 | 26.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
116.7B USD | 3.3 | 25.3 | 13.9 | 20.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 5.3 | 36.7 | 21.5 | 28.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45B EUR | 1.9 | 21.4 | 11.8 | 16.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.5B USD | 11.3 | 45.7 | 32.5 | 35.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.9 | 44.4 | 24.4 | 26.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48B USD | 2.2 | 27.2 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.8 | 24.8 | 17.5 | 19.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
